The Relationship Between Renal Stones and Primary Aldosteronism.
Chang CK, Chang CC, Wu VC, Geng JH, Lee HY.
Front Endocrinol (Lausanne). 2022 Feb 9;13:828839. doi: 10.3389/fendo.2022.828839. eCollection 2022.
A case of nephrocalcinosis associated with primary aldosteronism.
Yasuda K, Sasaki K, Yamato M, Rakugi H, Isaka Y, Hayashi T.
Intern Med. 2012;51(6):625-7. doi: 10.2169/internalmedicine.51.6543. Epub 2012 Mar 15.
Recurrent calcium nephrolithiasis associated with primary aldosteronism.
Shey J, Cameron MA, Sakhaee K, Moe OW.
Am J Kidney Dis. 2004 Jul;44(1):e7-12. doi: 10.1053/j.ajkd.2004.03.037.
Calcium and the kidney--from stones to molecules.
Suki WN.
Verh K Acad Geneeskd Belg. 1990;52(3):203-21; discussion 221-3.
Sodium transporters in health and disease.
Warnock DG.
Curr Opin Nephrol Hypertens. 1997 Jul;6(4):372-6. doi: 10.1097/00041552-199707000-00011.
Diphosphonate therapy in nephrocalcinosis.
McCredie DA, Powell HR, Rotenberg E.
Br J Urol. 1976 Apr;48(2):93-100. doi: 10.1111/j.1464-410x.1976.tb02988.x.
Renal calculi in primary hyperaldosteronism.
Kabadi UM.
Postgrad Med J. 1995 Sep;71(839):561-2. doi: 10.1136/pgmj.71.839.561.
Nephrocalcinosis: molecular insights into calcium precipitation within the kidney.
Sayer JA, Carr G, Simmons NL.
Clin Sci (Lond). 2004 Jun;106(6):549-61. doi: 10.1042/CS20040048.
Considerations about the molecular basis of some kidney tubule disorders in relation to inbreeding and population displacement.
García-Nieto VM, Claverie-Martín F, Perdomo-Ramírez A, Cárdoba-Lanus E, Ramos-Trujillo E, Mura-Escorche G, Tejera-Carreño P, Luis-Yanes MI; el Grupo RenalTube.
Nefrologia (Engl Ed). 2020 Mar-Apr;40(2):126-132. doi: 10.1016/j.nefro.2019.08.004. Epub 2019 Nov 27.
Molecular pathology of renal chloride channels in Dent's disease and Bartter's syndrome.
Thakker RV.
Exp Nephrol. 2000 Nov-Dec;8(6):351-60. doi: 10.1159/000020689.
